• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Alder Biopharmaceuticals Inc

+ Add to Watchlist

3A9:GR

12.050 EUR 0.221 1.80%

As of 02:02:29 ET on 08/21/2014.

Snapshot for Alder Biopharmaceuticals Inc (3A9)

Open: 11.650 Day's Range: 11.650 - 12.050 Volume: 0
Previous Close: 12.271 52wk Range: 7.169 - 15.702 1-Yr Rtn: -

Stock Chart for 3A9

No chart data available.
  • 3A9:GR 12.050
  • 1D
  • 1M
  • 1Y
12.271
Interactive 3A9 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 3A9

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -2.7170
Est. PEG Ratio -
Market Cap (M EUR) 371.18
Shares Outstanding (M) 30.80
30 Day Average Volume 19
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 3A9

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 3A9

Alder Biopharmaceuticals, Inc. provides pharmaceutical products and services. The Company offers identifies, develops, and manufactures antibody therapeutics to alleviate human suffering in cancer, pain, cardiovascular, and autoimmune and inflammatory disease areas. Alder Biopharmaceuticals operates in the United States.

Randall C SchatzmanPresident/CEO/Co-FounderMark J LittonChief Bus Ofcr/Treasurer/Secy
John A LathamChief Scientific Ofcr/Co-FounderLarry K BenedictSenior VP:Finance
More Company Profile & Key Executives for 3A9

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil